Comment on: risk of urinary tract infections associated with SGLT2 inhibitor use in patients with rheumatoid arthritis: a target trial emulation study: reply.
- DOI
- 10.1093/rheumatology/keaf666
- Published
- 2026 Feb 4
- Container
- Rheumatology (Oxford, England)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/rheumatology/keaf666,
title = {Comment on: risk of urinary tract infections associated with SGLT2 inhibitor use in patients with rheumatoid arthritis: a target trial emulation study: reply.},
author = {Dobashi N and Sada KE and Kudo M and Morishita S and Sasaki S and Suganuma N},
year = {2026},
journal = {Rheumatology (Oxford, England)},
doi = {10.1093/rheumatology/keaf666},
url = {https://doi.org/10.1093/rheumatology/keaf666}
}RIS
TY - JOUR TI - Comment on: risk of urinary tract infections associated with SGLT2 inhibitor use in patients with rheumatoid arthritis: a target trial emulation study: reply. AU - Dobashi N AU - Sada KE AU - Kudo M AU - Morishita S AU - Sasaki S AU - Suganuma N PY - 2026 JO - Rheumatology (Oxford, England) DO - 10.1093/rheumatology/keaf666 UR - https://doi.org/10.1093/rheumatology/keaf666 ER -
APA
N, D., KE, S., M, K., S, M., S, S., & N, S. (2026). Comment on: risk of urinary tract infections associated with SGLT2 inhibitor use in patients with rheumatoid arthritis: a target trial emulation study: reply.. Rheumatology (Oxford, England). https://doi.org/10.1093/rheumatology/keaf666
Source records
- pubmed · retrieved 2026-09-26T00:45:34.711Z